Ignite Creation Date:
2025-12-24 @ 2:05 PM
Ignite Modification Date:
2026-02-20 @ 4:44 PM
Study NCT ID:
NCT02318095
Status:
COMPLETED
Last Update Posted:
2023-10-26
First Post:
2014-12-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer
Sponsor:
Duke University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00058865
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None